Captopril Answer: C Q2
Ichtchenko K, Hata Y, Nguyen T, Ullrich B, Missler M, Moomaw C, et al
This is why injectable GHK-Cu in one body area can improve healing at distant locations, something topical application cannot replicate
Impaired ossification associated with skeletal malformations (e.g., bent limbs, scapula, clavicle, and pelvis) were observed at 2.5 mcg/kg/dose, resulting in systemic exposure that is 1-time the 20 mcg/day clinical dose, based on plasma AUC
Side Effects and Safety Considerations GHK-Cu demonstrates an excellent safety profile based on over 40 years of research, though most safety data derives from topical applications and animal studies